VaxGen settles with U.S. over canceled contract
- Share via
From Bloomberg News
VaxGen Inc., which cut half its workforce after losing a contract to make anthrax vaccine, said it was settling with the U.S. government for $11 million.
The agreement also releases the U.S. Health and Human Services Department and Brisbane, Calif.-based VaxGen of all liabilities related to contracts to develop anthrax vaccine, the company said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
